Back to search

Switzerland· 43679023

Vitalipid N Infant, Infusionszusatz, Emulsion

A other combinations of nutrients product containing retinoli palmitas, ergocalciferolum, int-rac-alpha-tocopherolum, phytomenadionum, registered in Switzerland by Fresenius Kabi (Schweiz) AG and dispensed under Swissmedic category B.

Cat B (Swissmedic)ATC V06DX

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedVitalipid N Infant, Infusionszusatz, …ATCV06DXREGISTER NO.43679023PACKS LISTED0CHECKEDSeptember 12, 2026

The record

At a glance

Swissmedic (Switzerland)
Active substance
retinoli palmitas, ergocalciferolum, int-rac-alpha-tocopherolum, phytomenadionum
Manufacturer
Fresenius Kabi (Schweiz) AG
Country
Switzerland (CH)
ATC code
V06DX
ATC class
Other combinations of nutrients
Swissmedic category
B
Reimbursed
No
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/3e7a2f4d-8029-41ec-ad9e-c9a7356dd61a
GET /v1/drugs/3e7a2f4d-8029-41ec-ad9e-c9a7356dd61a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{}

See everything about retinoli palmitas, ergocalciferolum, int-rac-alpha-tocopherolum, phytomenadionum.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.